ACLY and antiphospholipid syndrome: Lupus anticoagulant (LAC), anticardiolipin antibodies (aCL) and anti-β2 glycoprotein I antibodies (aβ2GPI) are associated with thrombosis, thrombocytopenia and obstetrical morbidity, and are included in the international classification criteria for antiphospholipid syndrome (APS) (55).